C

Shanghai Pharmaceuticals Holding Co., Ltd SHPMY

$7.24 -$0.15-1.97% OTC PK
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
52-Week Range
P/E (TTM)
EPS (TTM)
Access our Premium Ratings
Get Access

Rating

Reward
Risk

Rating Factors

Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index

Company Overview

Shanghai Pharmaceuticals Holding Co., Ltd. is a Chinese pharmaceutical and healthcare conglomerate engaged in pharmaceutical manufacturing, distribution, retail pharmacy operations, and healthcare services. The company operates across the broader healthcare and life sciences industries, with activities spanning prescription medicines, over-the-counter products, traditional Chinese medicine (TCM), medical devices, and healthcare supply chain management. Listed on both the Shanghai Stock Exchange and the Hong Kong Stock Exchange, the company is among the largest pharmaceutical distributors and manufacturers in China by revenue and scale.

The company’s primary revenue drivers are its Pharmaceutical Distribution and Pharmaceutical Manufacturing businesses. Distribution operations supply hospitals, clinics, pharmacies, and healthcare institutions across China, while manufacturing operations include chemical drugs, biologics, TCM products, and specialty medicines. Shanghai Pharmaceuticals has evolved from a regional pharmaceutical operator into a national healthcare platform through mergers, acquisitions, and integration of state-owned pharmaceutical assets. The company maintains strategic advantages through its nationwide logistics network, hospital relationships, vertically integrated operations, and strong positioning in China’s regulated healthcare market.

Data compiled by narrative technology. May contain errors.
Sector
--
Industry
--

Income Statement

Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)

Balance Sheet

Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)

Cash Flow

Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)

Filings

Filing Date
Thursday, August 27, 2026
Period Date
Tuesday, June 30, 2026
Next Filing
Week of Oct 26 and 30 (est)

Price History

Loading...
Beta
--
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
--
2-Year Total Return
--
3-Year Total Return
--
5-Year Total Return
--
52-week Low
52-week High

Valuation

Market Cap
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)

Dividends and Shares

Shares Outstanding
Dividend Per Share (Most Recent)
Dividend Per Share (TTM)

Corporate Info

Phone Number
86 21 6373 0908
Address
Shanghai Pharmaceutical Building
No. 200 Taicang Road
Shanghai, 200020
Country
Year Founded

Headlines

There are no news to display.